Fresenius Kabi
Fresenius Kabi
Explore linked clinical trials.7 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Safety Study to Evaluate the Occurrence of EFAD in Pediatric Patients With PNAC Who Require More Than Eight Weeks of Omegaven Treatment | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Nutritional and Metabolic Diseases, Precursor Cell Lymphoblastic Leukemia-Lymphoma, childhood acute lymphoblastic leukemia, hematologic disorder, immune system disorder, immunoproliferative disorder, leukemia, lymphatic system disorder, lymphoid leukemia, lymphoproliferative syndrome, neoplasm, nutritional deficiency disease, nutritional disorder | Recruiting | Not stated | 2026-08-14 | NCT06274788 | |
| Plant-based Versus Animal-based Oral Nutritional Supplements | Risk of Malnutrition | Recruiting | Not applicable | 2026-08-11 | NCT07399886 | |
| The FORCE Trial Pilot: Fish Oil-enriched Nutrition for Radiotherapy in Cancer of the hEad and Neck | Atrophy, Head and Neck Neoplasms, Neoplasms by Site, Neurologic Manifestations, Neuromuscular Manifestations, Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, Sarcopenia, Signs and Symptoms, muscular atrophy, neoplasm, nervous system disorder | Not yet recruiting | Phase 1 / Phase 2 | 2026-08-07 | NCT07180576 | |
| Safety Study of SMOFlipid to Evaluate the Risk of Developing EFAD and/or PNAC in Pediatric and Adult Patients | Child Malnutrition, Child Nutrition Disorders, Nutritional and Metabolic Diseases, nutritional deficiency disease, nutritional disorder | Recruiting | Phase 4 | 2026-07-17 | NCT06049680 | |
| Glycaemic Index Measurement of an Oral Nutritional Supplement With Biomarker Assessment and Lifestyle Monitoring in Healthy Participants | Healthy Participants | Not yet recruiting | Not applicable | 2026-03-23 | NCT07479251 | |
| Improved Muscle Metabolism by Combination of Muscle Activation and Protein Substitution ( IMEMPRO ) | Atrophy, Morphological and Microscopic Findings, Neurologic Manifestations, Neuromuscular Manifestations, Nutritional and Metabolic Diseases, Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, Protein Deficiency, Signs and Symptoms, muscular atrophy, nervous system disorder, nutritional deficiency disease, nutritional disorder, protein-energy malnutrition | Recruiting | Not applicable | 2026-03-03 | NCT05919940 | |
| Achieving nuTritional Target in criticAlly Ill patieNts With iMpairEd gastroiNtesTinal Dysfunction | Critical Illness, Digestive System Diseases, Disease Attributes, Hyperphagia, Neurologic Manifestations, Nutritional and Metabolic Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Protein Deficiency, Signs and Symptoms, Signs and Symptoms, Digestive, digestive system disorder, gastroparesis, intestinal disorder, malabsorption syndrome, metabolic disease, nutritional deficiency disease, nutritional disorder, palsy, stomach disorder | Recruiting | Not applicable | 2024-11-06 | NCT06510348 |